世界の皮下植込み型除細動器市場予測（～2028年）：心室性頻脈、肥大型心筋症、心室性異形成症、その他

• 英文タイトル：Global Subcutaneous Implantable Cardioverter Defibrillator Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8427 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

皮下植込み型除細動器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の皮下植込み型除細動器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 皮下植込み型除細動器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・心室性頻脈、肥大型心筋症、心室性異形成症、その他 用途別セグメントは次のように区分されます。 ・病院、専門クリニック、外来手術センター、在宅医療 世界の皮下植込み型除細動器市場の主要な市場プレーヤーは以下のとおりです。 ・Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、皮下植込み型除細動器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な皮下植込み型除細動器メーカーの企業概要、2019年～2022年までの皮下植込み型除細動器の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な皮下植込み型除細動器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別皮下植込み型除細動器の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの皮下植込み型除細動器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での皮下植込み型除細動器市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および皮下植込み型除細動器の産業チェーンを掲載しています。 ・第13、14、15章では、皮下植込み型除細動器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：心室性頻脈、肥大型心筋症、心室性異形成症、その他 ・用途別分析2017年-2028年：病院、専門クリニック、外来手術センター、在宅医療 ・皮下植込み型除細動器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・皮下植込み型除細動器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮下植込み型除細動器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮下植込み型除細動器の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・皮下植込み型除細動器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Subcutaneous Implantable Cardioverter Defibrillator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Subcutaneous Implantable Cardioverter Defibrillator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Subcutaneous Implantable Cardioverter Defibrillator global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ventricular Tachycardia segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Subcutaneous Implantable Cardioverter Defibrillator include Abbott, Koninklijke Philips, Nihon Kohden Corporation, Medtronic, and Boston Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Subcutaneous Implantable Cardioverter Defibrillator market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ventricular Tachycardia
Hypertrophic Cardiomyopathy
Ventricular Dysplasia
Others
Market segment by Application can be divided into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Care
The key market players for global Subcutaneous Implantable Cardioverter Defibrillator market are listed below:
Abbott
Koninklijke Philips
Nihon Kohden Corporation
Medtronic
Boston Scientific
MicroPort Scientific
ClearPoint Neuro
BIOTRONIK SE
ZOLL Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Implantable Cardioverter Defibrillator product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Subcutaneous Implantable Cardioverter Defibrillator, with price, sales, revenue and global market share of Subcutaneous Implantable Cardioverter Defibrillator from 2019 to 2022.
Chapter 3, the Subcutaneous Implantable Cardioverter Defibrillator competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Implantable Cardioverter Defibrillator breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Implantable Cardioverter Defibrillator market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Subcutaneous Implantable Cardioverter Defibrillator.
Chapter 13, 14, and 15, to describe Subcutaneous Implantable Cardioverter Defibrillator sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Subcutaneous Implantable Cardioverter Defibrillator Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ventricular Tachycardia
1.2.3 Hypertrophic Cardiomyopathy
1.2.4 Ventricular Dysplasia
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Home Care
1.4 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size & Forecast
1.4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume (2017-2028)
1.4.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price (2017-2028)
1.5 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity Analysis
1.5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Total Production Capacity (2017-2028)
1.5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Implantable Cardioverter Defibrillator Market Drivers
1.6.2 Subcutaneous Implantable Cardioverter Defibrillator Market Restraints
1.6.3 Subcutaneous Implantable Cardioverter Defibrillator Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.1.4 Abbott Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Koninklijke Philips
2.2.1 Koninklijke Philips Details
2.2.2 Koninklijke Philips Major Business
2.2.3 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.2.4 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Nihon Kohden Corporation
2.3.1 Nihon Kohden Corporation Details
2.3.2 Nihon Kohden Corporation Major Business
2.3.3 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.3.4 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.4.4 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.5.4 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 MicroPort Scientific
2.6.1 MicroPort Scientific Details
2.6.2 MicroPort Scientific Major Business
2.6.3 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.6.4 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ClearPoint Neuro
2.7.1 ClearPoint Neuro Details
2.7.2 ClearPoint Neuro Major Business
2.7.3 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.7.4 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BIOTRONIK SE
2.8.1 BIOTRONIK SE Details
2.8.2 BIOTRONIK SE Major Business
2.8.3 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.8.4 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZOLL Medical
2.9.1 ZOLL Medical Details
2.9.2 ZOLL Medical Major Business
2.9.3 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Product and Services
2.9.4 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Subcutaneous Implantable Cardioverter Defibrillator Breakdown Data by Manufacturer
3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Subcutaneous Implantable Cardioverter Defibrillator
3.4 Market Concentration Rate
3.4.1 Top 3 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer Market Share in 2021
3.4.2 Top 6 Subcutaneous Implantable Cardioverter Defibrillator Manufacturer Market Share in 2021
3.5 Global Subcutaneous Implantable Cardioverter Defibrillator Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Subcutaneous Implantable Cardioverter Defibrillator Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size by Region
4.1.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Region (2017-2028)
4.1.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2028)
4.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.3 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.4 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.5 South America Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
4.6 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Type (2017-2028)
5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
5.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Application (2017-2028)
6.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
6.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
7.2 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
7.3 North America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
7.3.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
7.3.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
8.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
8.3 Europe Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
8.3.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
8.3.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
9.2 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
9.3 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
10.2 South America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
10.3 South America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
10.3.1 South America Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
10.3.2 South America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
11.2 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
11.3 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Subcutaneous Implantable Cardioverter Defibrillator and Key Manufacturers
12.2 Manufacturing Costs Percentage of Subcutaneous Implantable Cardioverter Defibrillator
12.3 Subcutaneous Implantable Cardioverter Defibrillator Production Process
12.4 Subcutaneous Implantable Cardioverter Defibrillator Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Subcutaneous Implantable Cardioverter Defibrillator Typical Distributors
13.3 Subcutaneous Implantable Cardioverter Defibrillator Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---